Form 8-K - Current report:
SEC Accession No. 0001493152-22-011829
Filing Date
2022-05-02
Accepted
2022-05-02 17:14:05
Documents
18
Period of Report
2022-04-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 58404
2 ex3-1.htm EX-3.1 141740
3 ex3-2.htm EX-3.2 136797
4 ex10-1.htm EX-10.1 273315
5 ex10-2.htm EX-10.2 110766
6 ex99-1.htm EX-99.1 15878
7 ex99-1_001.jpg GRAPHIC 3687
  Complete submission text file 0001493152-22-011829.txt   1068954

Data Files

Seq Description Document Type Size
8 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abeo-20220429.xsd EX-101.SCH 2989
9 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abeo-20220429_lab.xml EX-101.LAB 34240
10 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abeo-20220429_pre.xml EX-101.PRE 22379
12 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3722
Mailing Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019
Business Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15771 | Film No.: 22883197
SIC: 2834 Pharmaceutical Preparations